Kelly A. Demerino
Corporate Officer/Principal en NUVO PHARMACEUTICALS INC. .
Perfil
Kelly A.
Demerino is currently working as the Vice President-Financial Operations at Nuvo Pharmaceuticals, Inc. Prior to this role, Ms. Demerino attended Mount Allison University, where they completed their undergraduate degree.
Cargos activos de Kelly A. Demerino
| Empresas | Cargo | Inicio |
|---|---|---|
| NUVO PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/01/2021 |
Formación de Kelly A. Demerino.
| Mount Allison University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Kelly A. Demerino
